Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Catheter Precision, Inc. Director's Dealing 2023

Mar 27, 2023

35479_dirs_2023-03-27_546d1704-44be-4a3c-9f22-a873b9e2e69c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2023-03-23

Reporting Person: JENKINS DAVID A (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-23 Common Stock C 277597 Acquired 277597 Direct
2023-03-23 Common Stock C 709703 Acquired 709703 Indirect
2023-03-23 Common Stock C 2264 Acquired 2264 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-23 Series X Convertible Preferred Stock $0 C 277.597 Disposed Common Stock (2292339) Direct
2023-03-23 Series X Convertible Preferred Stock $0 C 709.703 Disposed Common Stock (5860540) Indirect
2023-03-23 Series X Convertible Preferred Stock $0 C 2.264 Disposed Common Stock (18691) Indirect

Footnotes

F1: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.

F2: Shares held by a partnership of which the reporting person is the managing member of the managing partner.

F3: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.

F4: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.

F5: Series X Convertible Preferred Stock has no expiration date.